← 產業報告目錄
Hyperpigmentation Disorder Treatment Market Size, Share & Trends Analysis Report, By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), By Region, Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-22頁數 180報告編號 INSIGHTACE-f339997d0b
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Valued at USD 6.98 Bn as of 2023, the global Hyperpigmentation Disorder Treatment Market is expected to climb to USD 12.54 Bn by 2031, reflecting a compound annual growth rate of 7.8% over the 2024–2031 period.
Hyperpigmentation Disorder Treatment encompasses challenges.
The market's upward path is bolstered by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, bolstered by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Hyperpigmentation Disorder Treatment Market Snapshot
Chapter 4. Global Hyperpigmentation Disorder Treatment Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Treatment Type Estimates & Trend Analysis
5.1. by Treatment Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Treatment Type:
5.2.1. Cosmeceutical
5.2.2. Light or Laser Therapy
5.2.3. Microdermabrasion
5.2.4. Chemical Peels
5.2.5. Cryotherapy
5.2.6. Others
Chapter 6. Market Segmentation 2: by Condition Estimates & Trend Analysis
6.1. by Condition & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Condition:
6.2.1. Melasma
6.2.2. Solar Lentigines
6.2.3. Post-Inflammatory Hyperpigmentation
6.2.4. Others
Chapter 7. Market Segmentation 3: by End-User Estimates & Trend Analysis
7.1. by End-User & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-User:
7.2.1. Hospitals
7.2.2. Dermatology Centers
7.2.3. Others
Chapter 8. Hyperpigmentation Disorder Treatment Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2019-2031
8.1.2. North America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by Condition, 2019-2031
8.1.3. North America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
8.1.4. North America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2019-2031
8.2.2. Europe Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by Condition, 2019-2031
8.2.3. Europe Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
8.2.4. Europe Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2019-2031
8.3.2. Asia Pacific Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by Condition, 2019-2031
8.3.3. Asia Pacific Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
8.3.4. Asia Pacific Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2019-2031
8.4.2. Latin America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by Condition, 2019-2031
8.4.3. Latin America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
8.4.4. Latin America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by Treatment Type, 2019-2031
8.5.2. Middle East & Africa Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by Condition, 2019-2031
8.5.3. Middle East & Africa Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
8.5.4. Middle East & Africa Hyperpigmentation Disorder Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. AbbVie Inc,
9.2.2. Bayer AG,
9.2.3. Epipharm AG,
9.2.4. Galderma Laboratories,
9.2.5. Obagi Cosmeceuticals LLC,
9.2.6. Lutronic Corporation,
9.2.7. La Pristine,
9.2.8. L?oreal S.A,
9.2.9. Pierre Fabre Group,
9.2.10. Vivier Pharma USA
9.2.11. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們